Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Atenolol versus Losartan in Marfan's Syndrome.

Literature DB >> 25738680

Atenolol versus Losartan in Marfan's Syndrome.

Ronald V Lacro, Harry C Dietz, Lynn Mahony.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2015 PMID： 25738680 DOI： 10.1056/NEJMc1500128

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

7 in total

1. A Novel Murine Model of Marfan Syndrome Accelerates Aortopathy and Cardiomyopathy.

Authors: Nicholas B Cavanaugh; Lan Qian; Nicole M Westergaard; William J Kutschke; Ella J Born; Joseph W Turek
Journal: Ann Thorac Surg Date: 2017-03-27 Impact factor: 4.330

2. Cine-CMR partial voxel segmentation demonstrates increased aortic stiffness among patients with Marfan syndrome.

Authors: Parmanand Singh; Zaid Almarzooq; Noel C F Codell; Yi Wang; Mary J Roman; Richard B Devereux; Jonathan W Weinsaft
Journal: J Thorac Dis Date: 2017-04 Impact factor: 2.895

3. Postnatal Deletion of the Type II Transforming Growth Factor-β Receptor in Smooth Muscle Cells Causes Severe Aortopathy in Mice.

Authors: Jie Hong Hu; Hao Wei; Mia Jaffe; Nathan Airhart; Liang Du; Stoyan N Angelov; James Yan; Julie K Allen; Inkyung Kang; Thomas N Wight; Kate Fox; Alexandra Smith; Rachel Enstrom; David A Dichek
Journal: Arterioscler Thromb Vasc Biol Date: 2015-10-22 Impact factor: 8.311

Review 7. Transforming Growth Factor-β and the Renin-Angiotensin System in Syndromic Thoracic Aortic Aneurysms: Implications for Treatment.

Authors: Daan C H van Dorst; Nathalie P de Wagenaar; Ingrid van der Pluijm; Jolien W Roos-Hesselink; Jeroen Essers; A H Jan Danser
Journal: Cardiovasc Drugs Ther Date: 2020-12-07 Impact factor: 3.727

7 in total

Atenolol versus Losartan in Marfan's Syndrome.

1. A Novel Murine Model of Marfan Syndrome Accelerates Aortopathy and Cardiomyopathy.

2. Cine-CMR partial voxel segmentation demonstrates increased aortic stiffness among patients with Marfan syndrome.

3. Postnatal Deletion of the Type II Transforming Growth Factor-β Receptor in Smooth Muscle Cells Causes Severe Aortopathy in Mice.

4. Losartan Attenuates Degradation of Aorta and Lung Tissue Micromechanics in a Mouse Model of Severe Marfan Syndrome.

5. Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling.

Review 6. A review of thoracic aortic aneurysm disease.

Review 7. Transforming Growth Factor-β and the Renin-Angiotensin System in Syndromic Thoracic Aortic Aneurysms: Implications for Treatment.